You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cholinesterase inhibitors for rarer dementias associated with neurological conditions
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2015
|
| DOI | 10.1002/14651858.cd009444.pub3 |
| Pubmed ID | |
| Authors |
Ying Li, Shan Hai, Yan Zhou, Bi Rong Dong |
| Abstract |
Rarer dementias include Huntington's disease (HD), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), frontotemporal dementia (FTD), dementia in multiple sclerosis (MS) and progressive supranuclear palsy (PSP). Cholinesterase inhibitors, including donepezil, galantamine and rivastigmine, are considered to be the first-line medicines for Alzheimer's disease and some other dementias, such as dementia in Parkinson's disease. Cholinesterase inhibitors are hypothesised to work by inhibiting the enzyme acetylcholinesterase (AChE) which breaks down the neurotransmitter acetylcholine. Cholinesterase inhibitors may also lead to clinical improvement for rarer dementias associated with neurological conditions. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Bosnia and Herzegovina | 1 | 20% |
| France | 1 | 20% |
| Belgium | 1 | 20% |
| United States | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 339 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Czechia | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 335 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 45 | 13% |
| Student > Ph. D. Student | 42 | 12% |
| Student > Master | 42 | 12% |
| Researcher | 35 | 10% |
| Student > Postgraduate | 20 | 6% |
| Other | 51 | 15% |
| Unknown | 104 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 91 | 27% |
| Psychology | 36 | 11% |
| Nursing and Health Professions | 26 | 8% |
| Neuroscience | 23 | 7% |
| Biochemistry, Genetics and Molecular Biology | 11 | 3% |
| Other | 37 | 11% |
| Unknown | 115 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2023.
All research outputs
#3,135,154
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#5,776
of 11,499 outputs
Outputs of similar age
#37,726
of 271,980 outputs
Outputs of similar age from Cochrane database of systematic reviews
#123
of 259 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,980 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 259 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.